NovoRapid

DRUG6 trials

Sponsors

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, Arecor Limited, University of Ljubljana, Faculty of Medicine, Steno Diabetes Center Copenhagen

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Type 1 DiabetesType 1 Diabetes Mellitus

Phase 1

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

CompletedNCT03959514

Arecor LimitedDiabetes Mellitus, Type 1

Start: 2019-04-12End: 2019-08-08Updated: 2019-09-30

AT278 and NovoRapid® in Glucose Clamp Study

CompletedNCT04660305

Arecor LimitedDiabetes Mellitus, Type 1

Start: 2020-12-02End: 2021-06-11Updated: 2021-07-21

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

CompletedNCT05754424

Arecor LimitedDiabetes Mellitus, Type 2

Start: 2023-02-27End: 2024-02-12Updated: 2024-02-16

Phase 4

Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

CompletedNCT03328845

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludType 1 Diabetes Mellitus

Start: 2017-01-20End: 2021-11-20Updated: 2021-12-06

Unknown Phase

Fast Advanced Closed-Loop Therapy

CompletedNCT04853030

University of Ljubljana, Faculty of MedicineType 1 Diabetes

Start: 2021-04-06End: 2021-09-20Updated: 2021-10-01

A Trial of Three- and Seven-days Insulin Infusions Set

RecruitingNCT06532461

Steno Diabetes Center CopenhagenType 1 Diabetes

Start: 2024-07-20End: 2026-12-31Target: 80Updated: 2024-08-06

Related Papers

A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial

Diabetes Technology & Therapeutics2023-07-0528 citations